Figures & data
Figure 1. ADM gene expression and peptide level in male accessory sex glands. Gene expression level of ADM (A) and ADM peptide levels in the secretion (C) were highest in ventral prostate. Tissue, while little was secreted out ADM peptide was highest in seminal vesicle (B) among all the glands, while little was secreted out (C). ADM: adrenomedullin; *P < 0.01, vs. ventral prostate, #P < 0.01, vs. coagulating glands, Kruskal Wallis test; data presented as Mean ±SEM; N = 8 for tissue, N = 5 for the secretion
![Figure 1. ADM gene expression and peptide level in male accessory sex glands. Gene expression level of ADM (A) and ADM peptide levels in the secretion (C) were highest in ventral prostate. Tissue, while little was secreted out ADM peptide was highest in seminal vesicle (B) among all the glands, while little was secreted out (C). ADM: adrenomedullin; *P < 0.01, vs. ventral prostate, #P < 0.01, vs. coagulating glands, Kruskal Wallis test; data presented as Mean ±SEM; N = 8 for tissue, N = 5 for the secretion](/cms/asset/52fbaecb-8b68-46f3-b855-46607be8426e/iaan_a_695855_f0001_b.gif)
Figure 2. Cytokine mRNA expression levels in uterus tissue treated with different dosages of ADM for 4 hours in vitro. TNFα (A) and IL-6 (C) gene expression remained unchanged after treatment with ADM while IL-1β gene expression decreased significantly (B). ADM: adrenomedullin; TNF: tissue necrosis factor; IL: interleukin; P < 0.05, Newman-Keuls Multiple post test; data presented as Mean ±SEM; N = 5.
![Figure 2. Cytokine mRNA expression levels in uterus tissue treated with different dosages of ADM for 4 hours in vitro. TNFα (A) and IL-6 (C) gene expression remained unchanged after treatment with ADM while IL-1β gene expression decreased significantly (B). ADM: adrenomedullin; TNF: tissue necrosis factor; IL: interleukin; P < 0.05, Newman-Keuls Multiple post test; data presented as Mean ±SEM; N = 5.](/cms/asset/abaa41e7-6033-4374-8102-92a9b3b3aa24/iaan_a_695855_f0002_b.gif)
Figure 3. Percentage changes of cytokines in the culture medium after treatment with ADM for 4 hours in vitro. TNF α (A) and IL-6 (C) secretion was significantly decreased after treatment with ADM (*P < 0.05 vs. control, #P < 0.01 vs. control, +P < 0.01 vs. 10 nM ADM, Newman-Keuls Multiple post test). There was no difference in the IL-1β secretion (B) after ADM treatment. ADM: adrenomedullin; TNF: tissue necrosis factor; IL: interleukin; data were presented as Mean ±SEM; N = 9.
![Figure 3. Percentage changes of cytokines in the culture medium after treatment with ADM for 4 hours in vitro. TNF α (A) and IL-6 (C) secretion was significantly decreased after treatment with ADM (*P < 0.05 vs. control, #P < 0.01 vs. control, +P < 0.01 vs. 10 nM ADM, Newman-Keuls Multiple post test). There was no difference in the IL-1β secretion (B) after ADM treatment. ADM: adrenomedullin; TNF: tissue necrosis factor; IL: interleukin; data were presented as Mean ±SEM; N = 9.](/cms/asset/5f5d0935-5241-44bd-8169-10c913f9e2ed/iaan_a_695855_f0003_b.gif)
Figure 4. Number of leukocytes and macrophages in post coital (pc) uterus segment at different treatment groups. The number of leukocytes (A) and macrophages (B) were lower at 24 hpc than that at 1.5 hpc (*P < 0.01, LSD test).Infusion with the ADM receptor blocker decreased the number of the leukocytesand macrophages at 24 hpc (#P < 0.05, LSD test). ADM: adrenomedull in; data were presented as Mean ±SEM; N = 10.
![Figure 4. Number of leukocytes and macrophages in post coital (pc) uterus segment at different treatment groups. The number of leukocytes (A) and macrophages (B) were lower at 24 hpc than that at 1.5 hpc (*P < 0.01, LSD test).Infusion with the ADM receptor blocker decreased the number of the leukocytesand macrophages at 24 hpc (#P < 0.05, LSD test). ADM: adrenomedull in; data were presented as Mean ±SEM; N = 10.](/cms/asset/d644e71d-35d1-492d-8dc9-2c1d2edc1b7d/iaan_a_695855_f0004_b.gif)
Figure 5. ROS/DAPI fluorescence intensity ratios in isolated uterine epithelial cells treated for 2 hours in vitro. ADM significantly decreased the ROS level in the endometrial epithelial cells (A) (#P < 0.01 vs. control, one way ANOVA with Newman-Keuls multiple post test). ROS level in the epithelial cells decreased after post coital uterine fluid treatment (B). ROS: reactive oxygen species; ADM: adrenomedullin; (*P < 0.05 vs. control, one way ANOVA with Newman-Keuls multiple post test); N = 7.
![Figure 5. ROS/DAPI fluorescence intensity ratios in isolated uterine epithelial cells treated for 2 hours in vitro. ADM significantly decreased the ROS level in the endometrial epithelial cells (A) (#P < 0.01 vs. control, one way ANOVA with Newman-Keuls multiple post test). ROS level in the epithelial cells decreased after post coital uterine fluid treatment (B). ROS: reactive oxygen species; ADM: adrenomedullin; (*P < 0.05 vs. control, one way ANOVA with Newman-Keuls multiple post test); N = 7.](/cms/asset/fcf50de2-5cc7-4eaa-8c4c-aae535d4b7ac/iaan_a_695855_f0005_b.gif)
Table 1. Primers for amplification of genes using real time PCR.